ES2123558T3 - Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc. - Google Patents

Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.

Info

Publication number
ES2123558T3
ES2123558T3 ES92913343T ES92913343T ES2123558T3 ES 2123558 T3 ES2123558 T3 ES 2123558T3 ES 92913343 T ES92913343 T ES 92913343T ES 92913343 T ES92913343 T ES 92913343T ES 2123558 T3 ES2123558 T3 ES 2123558T3
Authority
ES
Spain
Prior art keywords
hcv
determination
procedure
antigens
peptidic antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92913343T
Other languages
English (en)
Other versions
ES2123558T5 (es
Inventor
Christoph Seidel
Gertraud Ehrlich-Weinreich
Hubert Bayer
Ursula-Henrike Wienhues
Gunther-Gerhard Jung
Hans Georg Ihlenfeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27202683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2123558(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2123558T3 publication Critical patent/ES2123558T3/es
Publication of ES2123558T5 publication Critical patent/ES2123558T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE DESCRIBEN NUEVOS ANTIGENOS DEL PEPTIDO HCV, QUE REPRESENTAN SECUENCIAS PARCIALES DEL C-100-3 Y EL ENV/CORE, CON LA ZONA C. ESTOS ANTIGENOS DE PEPTIDO SON ADECUADOS PARA LA DETERMINACION DE ANTICUERPOS HCV, COMO INMUNOGENES PARA LA OBTENCION DE ANTICUERPOS CONTRA HCV, Y COMO VACUNAS PARA LA OBTENCION DE SUSTANCIAS INYECTABLES CONTRA EL HCV.
ES92913343T 1991-07-04 1992-06-30 Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc. Expired - Lifetime ES2123558T5 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4122160 1991-07-04
DE4122160 1991-07-04
DE4141304 1991-12-14
DE4141304 1991-12-14
DE4209215A DE4209215A1 (de) 1991-07-04 1992-03-21 Hcv peptidantigene und verfahren zur bestimmung von hcv
DE4209215 1992-03-21

Publications (2)

Publication Number Publication Date
ES2123558T3 true ES2123558T3 (es) 1999-01-16
ES2123558T5 ES2123558T5 (es) 2004-06-01

Family

ID=27202683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92913343T Expired - Lifetime ES2123558T5 (es) 1991-07-04 1992-06-30 Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.

Country Status (10)

Country Link
US (3) US6183949B1 (es)
EP (2) EP0881231A3 (es)
JP (1) JP2774872B2 (es)
KR (1) KR970010925B1 (es)
AT (1) ATE171710T1 (es)
AU (1) AU652851B2 (es)
CA (1) CA2089576A1 (es)
DE (2) DE4209215A1 (es)
ES (1) ES2123558T5 (es)
WO (1) WO1993001210A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
EP1878797B1 (en) * 1992-07-16 2010-04-28 Advanced Life Science Institute, Inc Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
ES2231773T3 (es) 1993-05-05 2005-05-16 Common Services Agency Virus de la hepatitis c de tipo 4, 5 y 6.
PT992580E (pt) * 1993-11-04 2005-07-29 Innogenetics Nv Epitopos para celulas t humanas imunodominantes do virus da hepatite c
JPH10503473A (ja) * 1994-04-08 1998-03-31 アメリカ合衆国 細胞傷害性ｔリンパ球刺激およびｈｃｖ曝露診断用ｃ型肝炎ウイルスコアペプチド
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
WO1996004385A2 (en) 1994-07-29 1996-02-15 Innogenetics N.V. Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
EP0829488A4 (en) * 1995-04-28 1999-04-07 Srl Inc ANTIGENIC PEPTIDE SUBSTANCE AND IMMOTEST PROCEDURE
EP0947525A1 (en) * 1998-03-27 1999-10-06 Innogenetics N.V. Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
JP3514729B2 (ja) * 1998-07-30 2004-03-31 株式会社先端生命科学研究所 Ｃ型肝炎ウイルスの測定方法
ES2260059T3 (es) * 1999-09-29 2006-11-01 Diagnocure Inc. Rna mensajero del pca3 en tejidos benignos y malignos de prostata.
US7049060B2 (en) * 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
EP1357127A1 (de) * 2002-04-10 2003-10-29 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
WO2006058287A2 (en) * 2004-11-26 2006-06-01 The Texas A & M University System Immunologic assay for detection of autoantibodies to folate binding protein
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
WO2009034190A2 (en) * 2007-09-14 2009-03-19 Genimmune N.V. Affinity tag
KR101701198B1 (ko) 2008-06-19 2017-02-01 배리에이션 바이오테크놀로지스 아이엔씨. 인플루엔자를 치료하기 위한 조성물 및 방법
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
CN103282375B (zh) 2010-12-02 2017-01-11 比奥诺尔免疫有限公司 肽支架设计
US20140328876A1 (en) 2011-11-18 2014-11-06 Variation Biotechnologies Inc. Synthetic derivatives of mpl and uses thereof
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3640412A1 (de) 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
US5306620A (en) * 1987-07-08 1994-04-26 The Scripps Research Institute Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation
BR8807310A (pt) 1987-11-18 1990-03-13 Chiron Corp Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5191064A (en) 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
US5106727A (en) * 1989-04-27 1992-04-21 Life Technologies, Inc. Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
EP0445801A3 (en) * 1990-03-08 1992-07-01 Kuraray Co., Ltd. Peptide and its use
ES2152922T3 (es) * 1990-04-06 2001-02-16 Genelabs Tech Inc Epitopos del virus de la hepatitis c.
AU635124B2 (en) * 1990-04-16 1993-03-11 United Biomedical Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
US6172189B1 (en) * 1990-08-24 2001-01-09 Abbott Laboratories Hepatitis C assay utilizing recombinant antigens
ES2161682T3 (es) * 1990-11-03 2001-12-16 Dade Behring Marburg Gmbh Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion.
ATE144993T1 (de) * 1990-12-14 1996-11-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus
AU1459792A (en) * 1991-01-14 1992-08-27 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
IL124567A (en) * 1998-05-20 2008-08-07 Abic Biolog Lab Ltd DNA sequences of HEMORRHAGIC ENTERITIS virus, proteins encoded by them and their various uses

Also Published As

Publication number Publication date
JPH05506462A (ja) 1993-09-22
KR930702387A (ko) 1993-09-08
ES2123558T5 (es) 2004-06-01
DE59209512D1 (de) 1998-11-05
DE4209215A1 (de) 1993-01-07
EP0551460B2 (de) 2003-10-08
EP0881231A2 (de) 1998-12-02
KR970010925B1 (ko) 1997-07-02
WO1993001210A3 (de) 1993-04-15
CA2089576A1 (en) 1993-01-05
AU2197392A (en) 1993-02-11
AU652851B2 (en) 1994-09-08
US6592871B1 (en) 2003-07-15
US6183949B1 (en) 2001-02-06
EP0551460B1 (de) 1998-09-30
ATE171710T1 (de) 1998-10-15
JP2774872B2 (ja) 1998-07-09
US20030198644A1 (en) 2003-10-23
EP0551460A1 (de) 1993-07-21
WO1993001210A2 (de) 1993-01-21
EP0881231A3 (de) 2004-02-04

Similar Documents

Publication Publication Date Title
DE69333397D1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
HUP9902438A2 (hu) Parapoxvírus vektorok
ES2184769T3 (es) Metodos y composiciones para microencapsulacion de antigenos para utilizar como vacunas.
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
ES2058049T1 (es) Composicion peptidica.
MX9207113A (es) Fragmento de adn, peptido que comprende una proteina superficial ha de un virus de gripe a y vacuna que comprende tal peptido.
AR005945A1 (es) Composicion farmaceutica para la modulacion inmunitaria
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
ES2138784T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
DE68926300D1 (de) Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius
ES2126145T3 (es) Redireccionamiento de anticuerpos.
MX303646A (es) Sistema portador contra la hormona de liberacion de gonadotropina.
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
DE3884316D1 (de) Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung.
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
ES2059305T5 (es) Proteina del virus de la seudorrabia.
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
NZ235474A (en) Virus capable of inducing infectious bursal disease; assay and vaccine
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.
BR9808251B1 (pt) vacina, e, uso de uma proteìna isolada ou recombinante ou fragmento antigênico da mesma.
ES2058240T3 (es) Nuevos peptidos sinteticos inmunologicamente activos utiles para la preparacion de una vacuna antimalarica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551460

Country of ref document: ES